Boothbay Fund Management, LLC Biomea Fusion, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$4.23 - $10.1 $65,565 - $156,550
15,500 New
15,500 $156,000
Q1 2024

May 15, 2024
SELL
$13.92 - $19.5 $1.44 Million - $2.01 Million
-103,200 Reduced 77.36%
30,200 $451,000
Q4 2023

Feb 14, 2024
BUY
$8.37 - $19.8 $1.12 Million - $2.64 Million
133,400 New
133,400 $1.94 Million
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $1.07 Million - $2.06 Million
49,300 Added 601.22%
57,500 $1.26 Million
Q1 2023

May 15, 2023
BUY
$6.8 - $32.35 $55,760 - $265,270
8,200 New
8,200 $254,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $120M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email